InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by PETKANAS DEAN, Chairman & CEO. Insider active across 1 companies, notably Neuropathix, INC.. Cumulatively, 6 disclosures have been recorded. Total volume traded: €10k. The latest transaction was filed on 6 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€23410,000 shares@ €0.02340.1% of flow
Common Stock
SEC:0001607062-22-000413:0·
€2,422100,000 shares@ €0.02421.5% of flow
Common Stock
SEC:0001607062-22-000403:0·
€3,70789,000 shares@ €0.04174.7% of flow
Common Stock
SEC:0001607062-22-000004·
€3,70789,000 shares@ €0.04172.3% of flow
Common Stock
SEC:0001607062-22-000004:0·
€75,6751,875,000 shares@ €0.040495.3% of flow
Common Stock
SEC:0001607062-21-000244·
€75,6751,875,000 shares@ €0.040446.9% of flow
Common Stock
SEC:0001607062-21-000244:0·
6 of 6 declarations
About PETKANAS DEAN
Dean Petkanas is the Chief Executive Officer of Neuropathix, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Petkanas implements initiatives aimed at driving growth and enhancing profitability. His leadership and vision are essential for achieving the long-term goals of Neuropathix.
